Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in RPRX / Royalty Pharma plc

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Royalty Pharma plc (US:RPRX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 9,109 shares of Royalty Pharma plc. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (RPRX) in the form of stock options. The firm currently holds call options representing 76,600 of underlying shares valued at $3,674,502 USD and put options representing 41,600 of underlying shares valued at $1,995,552 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RPRX / Royalty Pharma plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ROYALTY PHARMA COM G7709Q104 0 -100.00 0
2026-02-11 2025-12-31 13F ROYALTY PHARMA COM G7709Q104 9,109 9,109 352 0.0002
2024-07-25 2024-06-30 13F ROYALTY PHARMA COM G7709Q104 0 -6,672 -100.00 0 0.0000
2024-04-25 2024-03-31 13F ROYALTY PHARMA COM G7709Q104 6,672 -27,943 -80.73 0 0.0001
2024-02-02 2023-12-31 13F ROYALTY PHARMA COM G7709Q104 34,615 -12,897 -27.14 1 -100.00 0.0006
2023-11-01 2023-09-30 13F ROYALTY PHARMA COM G7709Q104 47,512 20,816 77.97 1 0.0010
2023-08-04 2023-06-30 13F ROYALTY PHARMA COM G7709Q104 26,696 26,696 1 0.0007
2023-02-02 2022-12-31 13F ROYALTY PHARMA COM G7709Q104 0 -892 -100.00 0 -100.00
2022-11-04 2022-09-30 13F ROYALTY PHARMA COM G7709Q104 892 892 35 0.0000
2022-05-02 2022-03-31 13F ROYALTY PHARMA COM G7709Q104 0 -12,798 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 ROYALTY PHARMA COM G7709Q104 12,798 11,774 1,149.80 510 1,086.05 0.0005
2022-02-04 2021-12-31 13F ROYALTY PHARMA COM G7709Q104 1,024 0 43 0.0000
2021-10-28 2021-09-30 13F ROYALTY PHARMA COM G7709Q104 1,024 -705 -40.78 43 -38.57 0.0000
2021-08-12 2021-06-30 13F ROYALTY PHARMA COM G7709Q104 1,729 1,303 305.87 70 288.89 0.0001
2021-04-26 2021-03-31 13F ROYALTY PHARMA COM G7709Q104 426 426 -75.36 18 -74.29 0.0000
2020-10-14 2020-09-30 13F ROYALTY PHARMA COM G7709Q104 0 -76 -100.00 0 -100.00
2020-07-13 2020-06-30 13F ROYALTY PHARMA COM G7709Q104 76 76 3 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ROYALTY PHARMA CALL Call 76,600 153.64 3,675 215.09 n/a n/a n/a
2026-02-11 2025-12-31 13F ROYALTY PHARMA CALL Call 30,200 -63.13 1,167 58,200.00 n/a n/a n/a
2025-11-12 2025-09-30 13F ROYALTY PHARMA CALL Call 81,900 -47.13 3 -60.00 n/a n/a n/a
2025-08-05 2025-06-30 13F ROYALTY PHARMA CALL Call 154,900 -15.59 6 0.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ROYALTY PHARMA CALL Call 183,500 75.60 6 150.00 n/a n/a n/a
2025-02-11 2024-12-31 13F ROYALTY PHARMA CALL Call 104,500 -2.52 3 -33.33 n/a n/a n/a
2024-11-08 2024-09-30 13F ROYALTY PHARMA CALL Call 107,200 0.94 3 50.00 n/a n/a n/a
2024-07-25 2024-06-30 13F ROYALTY PHARMA CALL Call 106,200 93.80 3 100.00 n/a n/a n/a
2024-04-25 2024-03-31 13F ROYALTY PHARMA CALL Call 54,800 -19.17 2 0.00 n/a n/a n/a
2024-02-02 2023-12-31 13F ROYALTY PHARMA CALL Call 67,800 -26.46 2 -50.00 n/a n/a n/a
2023-11-01 2023-09-30 13F ROYALTY PHARMA CALL Call 92,200 -41.90 3 -50.00 n/a n/a n/a
2023-08-04 2023-06-30 13F ROYALTY PHARMA CALL Call 158,700 -18.87 5 -42.86 n/a n/a n/a
2023-04-27 2023-03-31 13F ROYALTY PHARMA CALL Call 195,600 95.80 7 133.33 n/a n/a n/a
2023-02-02 2022-12-31 13F ROYALTY PHARMA CALL Call 99,900 -25.06 4 -99.94 n/a n/a n/a
2022-11-04 2022-09-30 13F ROYALTY PHARMA CALL Call 133,300 -14.82 5,355 -18.60 n/a n/a n/a
2022-08-03 2022-06-30 13F ROYALTY PHARMA CALL Call 156,500 83.26 6,579 97.75 n/a n/a n/a
2022-05-02 2022-03-31 13F ROYALTY PHARMA CALL Call 85,400 39.54 3,327 36.46 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ROYALTY PHARMA CALL Call 61,200 93.06 2,438 82.21 n/a n/a n/a
2022-02-04 2021-12-31 13F ROYALTY PHARMA CALL Call 31,700 1,338 n/a n/a n/a
2021-10-28 2021-09-30 13F ROYALTY PHARMA CALL Call 31,700 -2.16 1,338 0.75 n/a n/a n/a
2021-08-12 2021-06-30 13F ROYALTY PHARMA CALL Call 32,400 8,403.94 1,328 -20.05 n/a n/a n/a
2021-04-26 2021-03-31 13F ROYALTY PHARMA CALL Call 381 155.70 1,661 122.95 n/a n/a n/a
2021-02-02 2020-12-31 13F ROYALTY PHARMA CALL Call 149 -15.82 745 0.13 n/a n/a n/a
2020-10-14 2020-09-30 13F ROYALTY PHARMA CALL Call 177 5,800.00 744 5,214.29 n/a n/a n/a
2020-07-13 2020-06-30 13F ROYALTY PHARMA CALL Call 3 14 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ROYALTY PHARMA PUT Put 41,600 177.33 1,996 244.56 n/a n/a n/a
2026-02-11 2025-12-31 13F ROYALTY PHARMA PUT Put 15,000 194.12 580 n/a n/a n/a
2025-11-12 2025-09-30 13F ROYALTY PHARMA PUT Put 5,100 -83.39 0 -100.00 n/a n/a n/a
2025-08-05 2025-06-30 13F ROYALTY PHARMA PUT Put 30,700 40.18 1 n/a n/a n/a
2025-05-12 2025-03-31 13F ROYALTY PHARMA PUT Put 21,900 184.42 1 n/a n/a n/a
2025-02-11 2024-12-31 13F ROYALTY PHARMA PUT Put 7,700 79.07 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ROYALTY PHARMA PUT Put 4,300 -79.23 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ROYALTY PHARMA PUT Put 20,700 -73.50 1 -100.00 n/a n/a n/a
2024-04-25 2024-03-31 13F ROYALTY PHARMA PUT Put 78,100 -55.52 2 -50.00 n/a n/a n/a
2024-02-02 2023-12-31 13F ROYALTY PHARMA PUT Put 175,600 -3.83 5 0.00 n/a n/a n/a
2023-11-01 2023-09-30 13F ROYALTY PHARMA PUT Put 182,600 138.38 5 100.00 n/a n/a n/a
2023-08-04 2023-06-30 13F ROYALTY PHARMA PUT Put 76,600 130.72 2 100.00 n/a n/a n/a
2023-04-27 2023-03-31 13F ROYALTY PHARMA PUT Put 33,200 -9.04 1 0.00 n/a n/a n/a
2023-02-02 2022-12-31 13F ROYALTY PHARMA PUT Put 36,500 8.63 1 -99.93 n/a n/a n/a
2022-11-04 2022-09-30 13F ROYALTY PHARMA PUT Put 33,600 226.21 1,350 211.78 n/a n/a n/a
2022-08-03 2022-06-30 13F ROYALTY PHARMA PUT Put 10,300 27.16 433 37.46 n/a n/a n/a
2022-05-02 2022-03-31 13F ROYALTY PHARMA PUT Put 8,100 -82.47 315 -82.89 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ROYALTY PHARMA PUT Put 46,200 216.44 1,841 198.86 n/a n/a n/a
2022-02-04 2021-12-31 13F ROYALTY PHARMA PUT Put 14,600 616 n/a n/a n/a
2021-10-28 2021-09-30 13F ROYALTY PHARMA PUT Put 14,600 0.00 616 3.01 n/a n/a n/a
2021-08-12 2021-06-30 13F ROYALTY PHARMA PUT Put 14,600 28,527.45 598 169.37 n/a n/a n/a
2021-04-26 2021-03-31 13F ROYALTY PHARMA PUT Put 51 -63.57 222 -68.29 n/a n/a n/a
2021-02-02 2020-12-31 13F ROYALTY PHARMA PUT Put 140 145.61 700 192.89 n/a n/a n/a
2020-10-14 2020-09-30 13F ROYALTY PHARMA PUT Put 57 239 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.